RE-BVS – Piemonte Repository

Sfoglia per AUTORE
NANNI C
Collezione AO Cuneo

Items : 7

Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 9;60:102017. doi: 10.1016/j.eclinm.2023.102017. eCollection 2023 Jun.

2023
AO Cuneo
AOU Città della Salute di Torino

Fanti S; Tacchetti P; Zucchetta P; Pascarella A; Villanova T; De Cicco G; Patriarca F; Fioritoni F; Priola C; Sgherza N; Grasso M; Versari A; Bertamini L; Gamberi B; Albano D; Zambello R; Racca M; Galli M; Belotti A; D'Agostino M; Rota-Scalabrini D; Capra A; Gay F; Oliva S; Zamagni E; Mancuso K; Barbato S; Boccadoro M; Musto P; et alii...

Standardization of (18)F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Jan 10;39(2):116-125. doi: 10.1200/JCO.20.00386. Epub 2020 Nov 5.

2021
AO Cuneo

Kraeber-Bodéré F; Bodet-Milin C; Cavo M; Fanti S; Perrot A; Gay F; Sonneveld P; Karlin L; Barbato S; Garderet L; Boccadoro M; Macro M; Patriarca F; Caillot D; Gallamini A; Gamberi B; Chauvie S; Tacchetti P; Versari A; Bailly C; Nanni C; Carlier T; Dozza L; Zamagni E; Moreau P;

Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1005-1015. doi: 10.1007/s00259-020-05049-6. Epub 2020 Oct

2021
AO Cuneo

Carlier T; Mateus D; Kraeber-Bodéré F; Bodet-Milin C; Touzeau C; Zamagni E; Moreau P; Chauvie S; Nanni C; Michaud AV; Jamet B; Morvan L; Bailly C;

Standardization of 18F-FDG PET/CT according to deauville criteria for MRD evaluation in newly diagnosed transplant eligible multiple myeloma (MM) patients: Joined analysis of two prospective randomized phase III trials in Haematologica

2019
AO Cuneo

Zamagni E; Nanni C; Dozza L; Carlier T; Tacchetti P; Versari A; Chauvie S; Gallamini A; Attal M; Gamberi B; Caillot D; Patriarca F; MacRo M; Boccadoro M; Garderet L; Fanti S; Perrot A; Gay F; Sonneveld P; Karlin L; Bodet-Milin C; Moreau P; Kraeber-Bodéré F; Cavo M;

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21

2018
AO Cuneo
AOU Città della Salute di Torino

Zamagni E; Cavo M; Gamberi B; Ghedini P; Gay F; Patriarca F; Gallamini A; Rensi M; Bellò M; Chauvie S; Bertone E; Bianchi A; Nanni C; Versari A; Fanti S;

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe). in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16.

2016
AO Cuneo
AOU Città della Salute di Torino

Fanti S; Cavo M; Gamberi B; Gay F; Patriarca F; Gallamini A; Rambaldi I; Bellò M; Rensi M; Bianchi A; Chauvie S; Versari A; Zamagni E; Nanni C;

In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Sep 1;32(25):2705-11. doi: 10.1200/JCO.2013.53.2838. Epub 2014 Jul 28.

2014
AO Cuneo

Coleman M; Stern R; Diehl L; Zinzani PL; Nanni C; Czuczman MS; Lamonica D; Specht L; Loft A; Danielewicz I; Biggi A; Malkowski B; Zaucha JM; Kostakoglu L; Hutchings M;